64 related articles for article (PubMed ID: 18825690)
1. Overexpression of TFAP2C in invasive breast cancer correlates with a poorer response to anti-hormone therapy and reduced patient survival.
Gee JM; Eloranta JJ; Ibbitt JC; Robertson JF; Ellis IO; Williams T; Nicholson RI; Hurst HC
J Pathol; 2009 Jan; 217(1):32-41. PubMed ID: 18825690
[TBL] [Abstract][Full Text] [Related]
2. CYP19A1 Expression Is Controlled by mRNA Stability of the Upstream Transcription Factor AP-2γ in Placental JEG3 Cells.
Kotomura N; Shimono Y; Ishihara S
Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38717933
[TBL] [Abstract][Full Text] [Related]
3. TFAP2C expression in breast cancer: correlation with overall survival beyond 10 years of initial diagnosis.
Perkins SM; Bales C; Vladislav T; Althouse S; Miller KD; Sandusky G; Badve S; Nakshatri H
Breast Cancer Res Treat; 2015 Aug; 152(3):519-31. PubMed ID: 26160249
[TBL] [Abstract][Full Text] [Related]
4. EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.
De Andrade JP; Park JM; Gu VW; Woodfield GW; Kulak MV; Lorenzen AW; Wu VT; Van Dorin SE; Spanheimer PM; Weigel RJ
Mol Cancer Ther; 2016 Mar; 15(3):503-11. PubMed ID: 26832794
[TBL] [Abstract][Full Text] [Related]
5. Crucial role of the transcription factors family activator protein 2 in cancer: current clue and views.
Jin C; Luo Y; Liang Z; Li X; Kołat D; Zhao L; Xiong W
J Transl Med; 2023 Jun; 21(1):371. PubMed ID: 37291585
[TBL] [Abstract][Full Text] [Related]
6. TRIM37 Augments AP-2γ Transcriptional Activity and Cellular Localization via K63-linked Ubiquitination to Drive Breast Cancer Progression.
Cui G; Gao Z; Chang S; Narwade N; Chen Y; Poudel B; Lei KMK; Zhang W; Li G; Poon TCW; Cheung E
Int J Biol Sci; 2022; 18(11):4316-4328. PubMed ID: 35864973
[TBL] [Abstract][Full Text] [Related]
7. Mutations in Noncoding
El Ghamrasni S; Quevedo R; Hawley J; Mazrooei P; Hanna Y; Cirlan I; Zhu H; Bruce JP; Oldfield LE; Yang SYC; Guilhamon P; Reimand J; Cescon DW; Done SJ; Lupien M; Pugh TJ
Mol Cancer Res; 2022 Jan; 20(1):102-113. PubMed ID: 34556523
[TBL] [Abstract][Full Text] [Related]
8. Co-expression of transcription factor AP-2beta (TFAP2B) and GATA3 in human mammary epithelial cells with intense, apicobasal immunoreactivity for CK8/18.
Raap M; Gierendt L; Werlein C; Kuehnle E; Kreipe HH; Christgen M
J Mol Histol; 2021 Dec; 52(6):1257-1264. PubMed ID: 34117603
[TBL] [Abstract][Full Text] [Related]
9. Molecular Functions of WWOX Potentially Involved in Cancer Development.
Taouis K; Driouch K; Lidereau R; Lallemand F
Cells; 2021 Apr; 10(5):. PubMed ID: 33946771
[TBL] [Abstract][Full Text] [Related]
10. Interaction of transcription factor AP-2 gamma with proto-oncogene PELP1 promotes tumorigenesis by enhancing RET signaling.
Liu J; Liu Z; Li M; Tang W; Pratap UP; Luo Y; Altwegg KA; Li X; Zou Y; Zhu H; Sareddy GR; Viswanadhapalli S; Vadlamudi RK
Mol Oncol; 2021 Apr; 15(4):1146-1161. PubMed ID: 33269540
[TBL] [Abstract][Full Text] [Related]
11. Functional genomics of AP-2α and AP-2γ in cancers: in silico study.
Kołat D; Kałuzińska Ż; Orzechowska M; Bednarek AK; Płuciennik E
BMC Med Genomics; 2020 Nov; 13(1):174. PubMed ID: 33213447
[TBL] [Abstract][Full Text] [Related]
12. METTL3 potentiates resistance to cisplatin through m
Wei J; Yin Y; Zhou J; Chen H; Peng J; Yang J; Tang Y
J Cell Mol Med; 2020 Oct; 24(19):11366-11380. PubMed ID: 32857912
[TBL] [Abstract][Full Text] [Related]
13. regSNPs-ASB: A Computational Framework for Identifying Allele-Specific Transcription Factor Binding From ATAC-seq Data.
Xu S; Feng W; Lu Z; Yu CY; Shao W; Nakshatri H; Reiter JL; Gao H; Chu X; Wang Y; Liu Y
Front Bioeng Biotechnol; 2020; 8():886. PubMed ID: 32850739
[TBL] [Abstract][Full Text] [Related]
14. Specific chromatin landscapes and transcription factors couple breast cancer subtype with metastatic relapse to lung or brain.
Cai WL; Greer CB; Chen JF; Arnal-Estapé A; Cao J; Yan Q; Nguyen DX
BMC Med Genomics; 2020 Mar; 13(1):33. PubMed ID: 32143622
[TBL] [Abstract][Full Text] [Related]
15. A
Wu VT; Kiriazov B; Koch KE; Gu VW; Beck AC; Borcherding N; Li T; Addo P; Wehrspan ZJ; Zhang W; Braun TA; Brown BJ; Band V; Band H; Kulak MV; Weigel RJ
Mol Cancer Res; 2020 Jan; 18(1):46-56. PubMed ID: 31619506
[TBL] [Abstract][Full Text] [Related]
16. The biological characteristics of transcription factors AP-2α and AP-2γ and their importance in various types of cancers.
Kołat D; Kałuzińska Ż; Bednarek AK; Płuciennik E
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30824562
[TBL] [Abstract][Full Text] [Related]
17. MiR-10a-5p targets TFAP2C to promote gemcitabine resistance in pancreatic ductal adenocarcinoma.
Xiong G; Huang H; Feng M; Yang G; Zheng S; You L; Zheng L; Hu Y; Zhang T; Zhao Y
J Exp Clin Cancer Res; 2018 Apr; 37(1):76. PubMed ID: 29615098
[TBL] [Abstract][Full Text] [Related]
18. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential new treatment response markers and therapeutic targets using a Gaussian process-based method in lapatinib insensitive breast cancer models.
Santra T; Roche S; Conlon N; O'Donovan N; Crown J; O'Connor R; Kolch W
PLoS One; 2017; 12(5):e0177058. PubMed ID: 28481952
[TBL] [Abstract][Full Text] [Related]
20. TFAP2C promotes lung tumorigenesis and aggressiveness through miR-183- and miR-33a-mediated cell cycle regulation.
Kang J; Kim W; Lee S; Kwon D; Chun J; Son B; Kim E; Lee JM; Youn H; Youn B
Oncogene; 2017 Mar; 36(11):1585-1596. PubMed ID: 27593936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
